<DOC>
	<DOCNO>NCT01721408</DOCNO>
	<brief_summary>This comparative study efficacy safety tigecycline imipenem/cilastatin hospitalize patient complicate intra-abdominal infection .</brief_summary>
	<brief_title>A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin Treat Complicated Intra-Abdominal Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Imipenem</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Cilastatin</mesh_term>
	<criteria>Hospitalized male female subject , least 18 year age . Complicated intraabdominal infection present two week duration . Minimal clinical criterion time intraabdominal infection diagnosis highly suspect intraabdominal infection . Anticipated length antibiotic therapy le 5 day likelihood subject complete course treatment . Intraabdominal infection know cause 1 bacterial pathogen susceptible study drug . Had accept nonstudy antibiotic 24 hr within 72 hrs enrollment except subject declare prior failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>